# Step 89: PC04.16 Evidence Closure and Next Mandatory Gap

Date: 2026-10-15. Documentation-only closure assessment continuing [Step 88](122-step88-pc04-16-functional-evidence-reconciliation.md).

**PC04.16 — SATISFIED — VERIFIED, with qualifications, for the established internal functional mapping.** The mapped implementation, recorded automated evidence and eight user-reported functional manual PASS results, together with accepted concurrency/security/audit evidence, support this decision. This is not OntarioMD acceptance or confirmation of applicability to an unestablished release. Outstanding mandatory functional-gap inventory: **11 IDs / three original packages**.

## 1. Actual Git checkpoint and scope

Observed branch: `feature/step-87-pc04-16-independent-refill-instructions`. HEAD: `a1645ae`. Starting tree is not clean; Step 88 remains untracked. No branch switch, staging, commit, merge, discard or overwrite is performed. This report is the only Step 89 addition; earlier reports remain historical checkpoints rather than being rewritten.

Starting modified tracked files (8):

```text
db/tenant-clinical/manifest.json
src/MicroEMR.Api/Controllers/PatientPrescriptionsController.cs
src/MicroEMR.Application/PatientPrescriptions/PatientPrescriptionModels.cs
src/MicroEMR.Auth/Data/SeedData.cs
src/MicroEMR.Infrastructure/PatientPrescriptions/PatientPrescriptionRepository.cs
src/MicroEMR.Web/Controllers/PatientPrescriptionsController.cs
src/MicroEMR.Web/Views/PatientPrescriptions/_Form.cshtml
src/MicroEMR.Web/Views/Patients/Details.cshtml
```

Starting untracked files (8):

```text
db/tenant-clinical/migrations/0073-prescription-refill-instructions.sql
docs/certification/118-step84-pc10-02-evidence-closure-next-gap.md
docs/certification/119-step85-pc04-16-scope-dependency-assessment.md
docs/certification/120-step86-pc04-16-medication-cdss-definition-mapping.md
docs/certification/121-step87-pc04-16-independent-refill-implementation.md
docs/certification/122-step88-pc04-16-functional-evidence-reconciliation.md
tests/MicroEMR.Api.Tests/PrescriptionRefillInstructionsTests.cs
tests/MicroEMR.Api.Tests/PrescriptionRefillSqlTests.cs
```

Final status adds only this untracked report: eight pre-existing modified files and nine untracked files. The existing Auth Postman callback change is preserved. No application/database files are changed by Step 89.

## 2. Requirement scope and implementation reused

Reuse [Step 86, sections 2–5](120-step86-pc04-16-medication-cdss-definition-mapping.md): PC04.16 requires the ability to capture refill quantity **and** refill duration/days' supply independently of first dispensing. Equal values are also valid. CDS-S DE09.011–.015 distinguish initial duration, refill duration, initial quantity, refill quantity and subsequent refill count. Directions/SIG do not replace these elements.

[Step 87](121-step87-pc04-16-independent-refill-implementation.md) records distinct nullable initial days/refill quantity-unit/refill days fields alongside existing initial quantity-unit and repeat count; Application validation; typed stored-procedure parameters and scoped reads; save/reopen/correction mapping; immutable final snapshots and separate chart/PDF display. Migration 0073 preserves legacy missing values without backfill or rewriting old artifacts. Existing permissions, tenant/patient scope, resolved clinical actors, provider checks, ownership, RowVersion and transactional lifecycle audit remain in place.

No medication reconciliation, licensed catalogue/safety supplier, pharmacy transmission, refill-use ledger or separately varying per-refill schedule is claimed. This closure does not close the broader prescription-print requirement PC04.05.

## 3. Automated evidence provenance and exact results

Reuse only the results already recorded in [Step 87, section 5](121-step87-pc04-16-independent-refill-implementation.md):

| Implementation-stage check | Recorded result and qualification |
| --- | --- |
| Initial development attempts | Sandboxed command stalled; separate Debug build failed because running API/Web processes locked output DLLs. No passing result is attributed to those blocked attempts. |
| First focused `Step87` selection | **19 passed / nine failed / zero skipped / 28 total**. Failures led to decimal-expectation and scoped-update corrections. |
| Targeted rerun after corrections, including edit/correction case | **10 passed / zero failed / zero skipped / 10 total**. Overlaps earlier cases; do not sum counts. |
| Final relevant Release build | **Passed, zero warnings / zero errors**. Built the relevant test project and its references, not a full solution build. |
| Final Release medication/output regression selection | **49 passed / zero failed / zero skipped / 49 total**, including all **30 new cases** and existing prescription/output regressions. Selection: `PatientPrescriptionFoundationTests`, `PrescriptionRefillInstructionsTests`, `PrescriptionRefillSqlTests`, `ClinicalPdfPreviewTests`. |

Recorded coverage includes real disposable SQL persistence/finalization, independent/equal/optional values, zero/multiple refills, validation, correction mappings, legacy upgrade/JSON/HTML retention, scoped mutation boundaries, concurrency, successful lifecycle audit/rollback, and actual PDF generation. These executions occurred during implementation; their results are neither fresh Step 89 runs nor independent deployed manual acceptance.

Historical regressions remain separate: the Step 46 **33 passed / one failed / zero skipped** gate and pre-existing manifest-length assertion remain qualified, as preserved in [Step 84](118-step84-pc10-02-evidence-closure-next-gap.md). Step 87's focused green selection does not repair or replace that gate, establish a new full API/Auth suite, or erase unrelated historical limitations. No tests or builds were rerun in Step 89.

## 4. Functional manual acceptance — eight PASS

Evidence source: the user's explicit Step 89 request reports seven additional Step 88 PASS results, **Notes: None**, in addition to the previously accepted different-quantity PASS. These are user-reported results, not Codex-executed observations. No additional IDs, screenshots, SQL rows, timestamps, deployed-version values or PDF-inspection artifacts are invented.

| Step 86 scenario | Recorded result | Provenance |
| --- | --- | --- |
| 1. Equal initial and refill values | **PASS** | New user report: Step 88 M1. |
| 2. Different initial and refill quantities | **PASS** | Previously accepted lifecycle evidence, preserved in Step 88. |
| 3. Different durations and optional fields | **PASS** | New user report: Step 88 M2. |
| 4. Zero refills | **PASS** | New user report: Step 88 M3. |
| 5. Three subsequent refills | **PASS** | New user report: Step 88 M4. |
| 6. Validation and unparsed directions | **PASS** | New user report: Step 88 M5. |
| 7. Legacy compatibility | **PASS** | New user report: Step 88 M6. |
| 8. Chart, print and PDF separation | **PASS** | New user report: Step 88 M7. |

These reports supersede Step 88's outstanding manual classifications for this mapped slice. Its procedures and evidence boundaries remain the interpretation of the reported checks; no unreported fixture-level observations are inferred. No functional scenario remains PENDING/DEFERRED on the supplied results, and no completed scenario should be repeated for this closure assessment.

## 5. Accepted concurrency, security and audit evidence

All results below are previously accepted **user-reported PASS**, reused without repetition:

| Area | Accepted result |
| --- | --- |
| RowVersion concurrency | Tab B's stale save rejected; Tab A's saved content remained intact. |
| Missing prescribing permission | Unauthorized mutations rejected. |
| Mismatched patient/prescription identifiers | Patient scoping preserved; no unauthorized content/mutation. |
| Cross-tenant identifiers | Tenant isolation preserved. |
| Prescriber draft ownership | Another prescriber cannot modify the owner's draft. |
| Patient-view API authorization | View-only list/read/artifact succeed; no-view account receives 403 for all three reads. |
| Patient-view Web authorization | No-view Web access denied; view-only chart and artifact access succeed after fresh Web sign-in. |
| Clinical audit correlation | User confirms actual SQL rows correlated to tenant, patient, prescription, resolved clinical actor, operation/time and successful saved state; zero successful mutation events attributable to rejected requests. |

The earlier missing-access-token exception did not recur after fresh sign-in. **Its root cause is not conclusively established.** This evidence closes the reported view-only access check; it does not prove a general authentication/session-recovery defect was fixed. No code fix, token-acquisition change or authentication troubleshooting is undertaken here. Clinical audit evidence is distinct from platform security-audit UI evidence.

## 6. Closure decision and retained qualifications

The bounded PC04.16 capability now has implemented storage/display/output support, recorded automated evidence, eight explicit functional manual PASS reports and accepted integrity/security/audit observations. No remaining material omission is demonstrated within the established mapping. Following the internal qualified-closure convention used in Step 84, record **SATISFIED — VERIFIED, with qualifications**. Earlier partial statuses remain accurate historical checkpoints; this report supplies the new evidence decision.

Qualifications remain explicit:

- **Source/release applicability:** Baseline folder 5.5 versus document 1.7 and CDS-S folder 5.2 DFU versus dictionary 2.1 Final/publication labels are not harmonized into proof of applicability to PCON-2024-02 Stage 3. Internal functional closure is conditional on the established mapping; it is not unconditional release certification. OntarioMD acceptance remains external.
- **Engineering policy versus authority:** positive whole days, numeric ranges/precision, nullable fields, quantity/unit completeness and zero-refill handling are documented engineering choices. The supplied definitions do not establish additional mandatory numeric bounds, unconditional per-record requiredness or authoritative defaults. Do not reinterpret these assumptions as OntarioMD rules. Application blank/null behavior is verified as reported; any unresolved authority-level default semantics remain qualified.
- **Bounded refill model:** a common prescription-level refill quantity/duration is the established minimal interpretation. No claim covers separately varying numbered refills, consumption tracking or automatic SIG arithmetic; expanded obligations would require additional authority.
- **Evidence provenance:** manual acceptance and audit correlation are user-reported, not independently executed by Codex. Raw fixture-level captures, actual deployed version and execution windows are not independently substantiated in this report; retain the original evidence through the existing evidence process. No artifact inspection is newly claimed.
- **Historical artifacts:** legacy compatibility now has user-reported PASS plus recorded automated JSON/HTML preservation. Generated historical PDF byte identity is not asserted; finalized artifacts must remain immutable even when lifecycle status/links legitimately change.
- **Automated gates:** retain the Step 46 33/1/0 qualification, earlier implementation-attempt failures and limited Step 87 test selection. No fresh full-suite/solution gate is claimed.
- **Other requirements:** PC04.05's remaining patient/clinic demographics, print/reprint attribution/timestamp and multipage omissions remain unresolved. PC10.01/.02 qualified closure, deferred PC10.02 audit and prior PC08/PC09/PC10.01 qualifications are unchanged. This PC04.16 security/audit acceptance does not backfill unrelated deferred scenarios.

## 7. Reconciled outstanding mandatory-gap inventory

Source: the explicit twelve-ID inventory in [Step 84, section 6](118-step84-pc10-02-evidence-closure-next-gap.md), carried through Steps 85–88. PC04.16 is an actual member of that list, so its closure removes one ID. No unrelated requirement is removed or reclassified.

| Original package | Remaining unresolved IDs | Count |
| --- | --- | --- |
| Medication/prescribing | PC04.01, PC04.05, PC04.06, PC04.07, PC04.09, PC04.14 | 6 |
| CPP | PC07.01, PC07.04, PC07.07, PC07.10 | 4 |
| Scheduling | PC09.03 | 1 |

Recalculated arithmetic: **6 + 4 + 1 = 11 mandatory functional-gap IDs**. Each original package still contains unresolved IDs, so **three packages remain**. This is the existing functional-gap inventory, not a declaration that all other mandatory requirements or externally qualified evidence are fully certified. Earlier inventory reports are preserved as dated history; this report is the current reconciliation.

## 8. Next mandatory gap and proposed Step 90

Recommend **PC04.05 — prescription output/print**, currently **PARTIAL**, from the remaining inventory. This follows the existing [Step 45 PC04 mapping and priority sequence](77-step45-baseline-1.7-reconciliation.md) and Step 87's explicit exclusions. PC04.01 is also unresolved but carries licensed catalogue/supplier dependencies; numerical ID order is not the proposed work order.

Recorded PC04.05 gaps include required patient HCN/address/phone and clinic address/phone; incomplete structured print content/identity; user/prescription timestamp visible on print/reprint; and multipage demographic/signature conditions. Step 87 and the PC04.16 manual results support separate initial/refill fields only; they do not establish whole-requirement PC04.05 coverage. These are reused mapped findings, not a fresh implementation inspection in Step 89.

Smallest next action: **Step 90 — PC04.05 Prescription Print Scope and Evidence Assessment**. Reconcile the existing clause-level output checklist against the current frozen snapshot/PDF and available patient/clinic/provider data; identify the precise remaining output/attribution/multipage gaps and any missing source/default semantics before proposing a bounded fix. Reuse PC04.16 output acceptance; do not rerun it, reopen frozen historical artifacts for mutation, redesign prescribing or start supplier integration.

If a focused development branch is later appropriate, suggest `feature/step-90-pc04-05-prescription-print`. It is not created here. Step 90 assessment/implementation has not started; no next-requirement code or verification work is authorized by this report.

## 9. Documentation checks and stop point

Checks are limited to the eight functional result rows, exact recorded automated counts/provenance, eleven distinct remaining IDs across three nonempty packages, local report links, whitespace and final Git scope. No application changes, database operations/migrations, browser operations, manual repeats, test/build reruns, staging, commits or merges.

Step 89 ends with qualified internal PC04.16 evidence closure and the Step 90 recommendation only.
